1. Home
  2. ENVA vs MLYS Comparison

ENVA vs MLYS Comparison

Compare ENVA & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$162.69

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$37.00

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
MLYS
Founded
2011
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ENVA
MLYS
Price
$162.69
$37.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$155.40
$46.40
AVG Volume (30 Days)
234.5K
1.7M
Earning Date
10-23-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
73.62
N/A
EPS
10.82
N/A
Revenue
$1,414,115,000.00
N/A
Revenue This Year
$159.72
N/A
Revenue Next Year
$16.16
N/A
P/E Ratio
$15.04
N/A
Revenue Growth
20.78
N/A
52 Week Low
$79.41
$8.24
52 Week High
$164.42
$47.65

Technical Indicators

Market Signals
Indicator
ENVA
MLYS
Relative Strength Index (RSI) 86.34 40.09
Support Level $134.00 $35.77
Resistance Level $132.15 $44.13
Average True Range (ATR) 4.32 1.93
MACD 2.90 -0.64
Stochastic Oscillator 98.56 14.95

Price Performance

Historical Comparison
ENVA
MLYS

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: